Yi Zhun Zhu Selected Research

Hyperplasia

12/2018	Critical role of histone demethylase Jumonji domain-containing protein 3 in the regulation of neointima formation following vascular injury.
1/2018	Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Zhun Zhu Research Topics

Disease

15	Inflammation (Inflammations) 12/2023 - 07/2005
13	Infarction (Infarctions) 06/2023 - 08/2003
11	Myocardial Infarction 10/2023 - 08/2003
11	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 01/2007
9	Rheumatoid Arthritis 12/2023 - 12/2016
7	Hypoxia (Hypoxemia) 12/2023 - 01/2007
7	Ischemia 06/2023 - 07/2006
6	Neoplasms (Cancer) 01/2024 - 06/2005
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2012
5	Stroke (Strokes) 12/2021 - 09/2009
5	Heart Failure 01/2019 - 04/2011
4	Atherosclerosis 01/2024 - 01/2018
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2023 - 09/2009
4	Ischemic Stroke 06/2023 - 09/2006
3	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 09/2006
3	Fibrosis (Cirrhosis) 01/2022 - 01/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2018 - 01/2010
3	Anemia 10/2017 - 01/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 09/2006
3	Body Weight (Weight, Body) 04/2012 - 08/2003
2	Insulin Resistance 01/2023 - 01/2022
2	Hypertension (High Blood Pressure) 01/2023 - 12/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 10/2017
2	Non-alcoholic Fatty Liver Disease 01/2023 - 06/2022
2	Brain Ischemia (Cerebral Ischemia) 12/2021 - 01/2010
2	Arthritis (Polyarthritis) 01/2021 - 01/2019
2	Neointima 01/2021 - 12/2018
2	Pneumonia (Pneumonitis) 12/2020 - 07/2005
2	Hyperplasia 12/2018 - 01/2018
1	Cognitive Dysfunction 05/2024
1	Cicatrix (Scar) 03/2024
1	Burns 03/2024
1	Chromosomal Instability (Chromosome Stability) 10/2023
1	Infections 06/2023
1	Neuroinflammatory Diseases 06/2023
1	Vascular Tissue Neoplasms 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Obesity 06/2022
1	Abdominal Obesity 06/2022
1	Metabolic Diseases (Metabolic Disease) 06/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022

Drug/Important Bio-Agent (IBA)

18	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2021 - 07/2005
16	leonurineIBA 10/2023 - 06/2009
13	Cysteine (L-Cysteine)FDA Link 03/2024 - 08/2009
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2007
9	EnzymesIBA 01/2019 - 08/2003
8	AntioxidantsIBA 06/2023 - 08/2003
6	Therapeutic UsesIBA 05/2024 - 09/2009
5	Neuroprotective AgentsIBA 06/2023 - 09/2009
5	sodium bisulfide (NaHS)IBA 10/2018 - 07/2005
4	LyasesIBA 01/2019 - 01/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 08/2003
3	CollagenIBA 11/2023 - 01/2019
3	LipidsIBA 06/2023 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 12/2021
3	CystathionineIBA 01/2019 - 07/2012
3	Histone DemethylasesIBA 01/2019 - 01/2018
3	IronIBA 10/2017 - 01/2016
3	HepcidinsIBA 10/2017 - 01/2016
2	Oxygen (Dioxygen)IBA 12/2023 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 08/2021
2	Pioglitazone (Actos)FDA Link 01/2023 - 04/2012
2	AlkaloidsIBA 01/2022 - 01/2010
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 01/2018
2	hirsutineIBA 01/2022 - 01/2011
2	Silicon Dioxide (Silica)FDA LinkGeneric 12/2021 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020 - 04/2005
2	GasotransmittersIBA 01/2019 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 09/2006
2	Delayed-Action PreparationsIBA 04/2015 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 07/2005
2	Superoxide DismutaseIBA 11/2010 - 08/2003
2	Malondialdehyde (Propanedial)IBA 11/2010 - 08/2009
2	S-allylcysteine (allyl cysteine)IBA 08/2009 - 11/2007
2	Messenger RNA (mRNA)IBA 08/2008 - 08/2003
2	Ramipril (Altace)FDA LinkGeneric 04/2005 - 08/2003
1	Sirtuin 2IBA 05/2024
1	trilobatinIBA 05/2024
1	CopperIBA 03/2024
1	HydrogelsIBA 03/2024
1	oxidized low density lipoproteinIBA 01/2024
1	Sirtuin 3IBA 10/2023
1	baohuoside IIBA 10/2023
1	histone H3 trimethyl Lys4IBA 10/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2023
1	ThiazolidinedionesIBA 01/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2023
1	Rosiglitazone (Avandia)FDA Link 01/2023
1	LigandsIBA 01/2023
1	Plant ExtractsIBA 06/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2022
1	IndolesIBA 06/2022
1	Tryptophan (L-Tryptophan)FDA Link 06/2022
1	indoleIBA 06/2022

Therapy/Procedure

7	Therapeutics 12/2023 - 09/2006
4	Immunotherapy 01/2024 - 01/2023